HOUSTON, Texas (KTRK) -- A 9-year-old Fort Bend County girl battling ovarian cancer was a special guest when "Good Morning America" made a visit to Houston Wednesday. Kaylee Tolleson captured the ...

Whenever actor Sam Sweere’s monologue about his recent lymphoma treatment — cheekily titled “A Good Cancer to Have” — gets too depressing, his stage partner and real-life wife, Leah, rings a bell. The ...

I hear that a lot. I didn’t quite know how to type it here. Some folks say it like this: You look good. As if they’re surprised — shocked that I still look like the guy they saw before I shared with y ...

Patients with limited metastatic/progressive cancers had good rates of local control and favorable survival with stereotactic body radiotherapy (SBRT) and no systemic therapy, according to a ...

For years, healthcare providers have been puzzled by an increase in colorectal cancer cases in young people. Now, new ...

Recently, I had a scare involving the health of my dog, Bowie. During a dental cleaning, his vet discovered a small, ...

Every October, breast cancer awareness campaigns remind us of the importance of screening and support. What's less discussed is the delicate issue of words. Those we say with good intentions, but ...

With continued investment in mRNA research, Donald Trump could turn the stalemate against cancer into a decisive breakthrough ...

Risk of death and cause of death 30 years after diagnosis as a proportion of 100 men. Grey figures indicate the proportion of men alive after 30 years, blue figures the proportion of men who died of ...

Important facts to keep in mind. re than 30 million Americans have a thyroid disorder and an excess of 60,000 Americans are affected by thyroid cancer annually. — -- intro: You probably don't ...

I hear that a lot. I didn’t quite know how to type it here. Some folks say it like this: You look good. As if they’re surprised — shocked that I still look like the guy they saw before I was diagnosed ...

Stereotactic body radiotherapy (SBRT) showed good local control and survival for limited metastatic/progressive cancers. Two-thirds of patients were alive at 2 years with minimal serious toxicity ...